« Previous
Next »
International Journal of Infectious Diseases
Volume 13, Issue 6
, Pages e360-e364
, November 2009
Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting
References
- World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision). Available at: www.who.int/hiv/pub/guidelines/adult/en/index.html (accessed January 2009).
- Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at: http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1 (accessed January 2009).
- Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr. 2006;41:53–58
- Prior antiretroviral therapy experience protects against zidovudine-related anaemia. HIV Med. 2007;8:465–471
- Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDS. 2008;22:337–344
- . Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy. HIV Med. 2007;8:483–490
- HIV in couples in South India: implications for prevention. Int J STD AIDS. 2005;16:442–445
- World Health Organization. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents, and adults in resource-limited settings: recommendations for a public health approach. Available at: http://www.who.int/hiv/pub/guidelines/ctx/en/index.html (accessed January 2009).
- Benson C, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. University of Colorado Health Sciences Center; Centers for Disease Control and Prevention; National Institutes of Health; University of Washington; 2005.
- . Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis. 2002;34:260–266
- Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS. 2001;15:473–480
- . Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005;40:219–225
- . Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003;36:79–85
- The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis. 2005;41:1525–1528
- Gender-based differences in treatment and outcome among HIV patients in South India. J Womens Health (Larchmt). 2008;17:1471–1475
- . Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med. 2004;116:S27–43
PII: S1201-9712(09)00072-1
doi: 10.1016/j.ijid.2008.11.030
© 2009 International Society for Infectious Diseases. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Infectious Diseases
Volume 13, Issue 6
, Pages e360-e364
, November 2009
